Loading news...
Shares of Icon Plc (NASDAQ: ICLR - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twenty-two research firms that are covering the stock, Marketbeat.com reports. Twelve research analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and two have assigned a strong buy recommendation
Alignment Healthcare (NASDAQ: ALHC - Get Free Report) and Icon (NASDAQ: ICLR - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations. Volatility and Risk Alignment Healthcare has a beta of
Eldred Rock Partners LLC grew its holdings in shares of Icon Plc (NASDAQ: ICLR) by 12.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 59,017 shares of the medical research company's stock after purchasing an additional 6,390 shares during
Coho Partners Ltd. trimmed its stake in shares of Icon Plc (NASDAQ: ICLR) by 34.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 152,503 shares of the medical research company's stock after selling 78,840 shares during
Exploring the Fund's Recent Portfolio Adjustments Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2
Bamco Inc. NY trimmed its holdings in shares of Icon Plc (NASDAQ: ICLR) by 2.0% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 690,623 shares of the medical research company's stock after selling 13,862 shares during the quarter.
California Public Employees Retirement System increased its position in shares of Icon Plc (NASDAQ: ICLR) by 4.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 155,062 shares of the medical research company's stock after acquiring an additional 7,107 shares
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of our 2023 survey, while the second survey focused exclusively on trends in the rapidly growing Chinese biotech market. In total, both surveys captured insights from more than 260 biotech professionals and venture capital executives across the US, Europe, Asia-Pacific (APAC).
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges clinical trial sites face during study startup. The findings underscore the need for a site-centric, collaborative approach to overcome bottlenecks and enhance trial activation timelines. The survey, conducted in June 2025 among just over 100 principal investigators and senior clinical trial site personnel, gathered per.
ICON Public Limited Company ( ICLR ) Jefferies London Healthcare Conference 2025 November 19, 2025 4:00 AM EST Company Participants Barry Balfe - CEO & Director Nigel Clerkin - Chief Financial Officer Conference Call Participants David Windley - Jefferies LLC, Research Division Presentation David Windley Jefferies LLC, Research Division All right. Good morning, everybody.
Artisan Partners Limited Partnership boosted its stake in Icon Plc (NASDAQ: ICLR) by 67.4% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,184,870 shares of the medical research company's stock after acquiring an additional 2,893,946 shares during the period. Icon accounts for
Allworth Financial LP raised its holdings in Icon Plc (NASDAQ: ICLR) by 64.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,396 shares of the medical research company's stock after buying an additional 547 shares during the quarter. Allworth Financial LP's
We initiated seven new positions across themes including Japanese industrials, measured gold exposure and businesses with strong links to emerging markets. We initiated small positions in two companies with gold-linked cash flows: Franco-Nevada (FNV) and Agnico Eagle Mines (AEM). We exited four positions in the quarter, two REITs and two health care companies.
Insights from Glenview Capital Management's Third Quarter 2025 13F Filing Larry Robbins (Trades, Portfolio) recently submitted the 13F filing for the third qua
Exploring the Strategic Moves of Brandes Investment Partners, LP (Trades, Portfolio) in Q3 2025 Brandes Investment Partners, LP (Trades, Portfolio) recently su
The vacation brand is ramping up on memory-making with adventure-filled lineups, including the world's best family vacation, Icon of the Seas, delivering unforgettable vacations from Galveston MIAMI , Nov. 12, 2025 /PRNewswire/ -- The ship that revolutionized family vacations is set to deliver the biggest adventures yet from Texas. The show-stopping Icon of the Seas will sail from Galveston for the first time starting August 2027, joining Royal Caribbean's new action-packed lineup of unforgettable getaways for the 2027-28 season.
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the Jefferies London Healthcare Conference.
Invesco International Small-Mid Company Fund outperformed most in the real estate and consumer staples sectors due to stock selection. The fund's underweight in real estate also added to relative return. The fund underperformed most in healthcare, information technology and materials due to stock selection.
Leading News Distribution and Communications Platform Reinforces Commitment to PR Education, Innovation, and Industry Excellence RALEIGH, NORTH CAROLINA / ACCESS Newswire / October 24, 2025 / ACCESS Newswire, one of North America's top three press release distribution and communications platforms, today announced its participation as a Diamond Sponsor at PRSA ICON 2025, taking place October 28th-30th in Washington D.C. The company will also serve as the Title Sponsor of the PRSA Educators Academy Summit, held in conjunction with ICON at the same venue.
ICON Public Limited Company (NASDAQ:ICLR ) Q3 2025 Earnings Call October 23, 2025 8:00 AM EDT Company Participants Kate Haven - Vice President of Investor Relations Steven Cutler Barry Balfe - CEO & Director Nigel Clerkin - Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink Partners LLC, Research Division Justin Bowers - Deutsche Bank AG, Research Division Jailendra Singh - Truist Securities, Inc., Research Division Patrick Donnelly - Citigroup Inc., Research Division Jack Meehan - Nephron Research LLC Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division Charles Rhyee - TD Cowen, Research Division Michael Ryskin - BofA Securities, Research Division David Windley - Jefferies LLC, Research Division Kyle Crews - UBS Investment Bank, Research Division Luke Sergott - Barclays Bank PLC, Research Division Christine Rains - William Blair & Company L.L.C.